Sharps Technology Begins Shipping Smart Safety Syringes

Sharps Technology, Inc. ( (STSS) ) has provided an announcement.

On June 4, 2025, Sharps Technology announced the commencement of shipments for its SecureGard™ and SoloGard™ smart safety syringes, marking its transition to a commercial-stage, revenue-generating company. The shipments include a $400,000 order under a $50 million supply agreement with a U.S. company and a $100,000 order to a Hungarian vaccine provider, reflecting growing demand for its products. Additionally, Sharps began shipping 200,000 units of low dead space syringes to a Swiss company for use in specialized injection pens. These developments underscore Sharps’ ability to serve diverse markets and meet technical requirements, supported by significant upgrades to its Hungary-based manufacturing facility.

More about Sharps Technology, Inc.

Sharps Technology is an innovative medical device and pharmaceutical packaging company that offers patented, best-in-class smart-safety syringe products to the healthcare industry. The company’s product lines focus on providing ultra-low waste capabilities and incorporate syringe technologies with both passive and active safety features. Sharps also designs products with specialized copolymer technology to support the prefillable syringe market segment, and it operates a manufacturing facility in Hungary.

Average Trading Volume: 695,954

Technical Sentiment Signal: Sell

Current Market Cap: $3.64M

See more data about STSS stock on TipRanks’ Stock Analysis page.